AlzeCure’s neuropathic pain candidate study reaches crucial phase
Research concerns ACD440 – a non-opioid drug which treats peripheral neuropathic pain
Read More
Tag: neuropathic
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
